Related Experiment Videos
Surgical alternatives for heart failure
S F Bolling1, I A Smolens, F D Pagani
1Section of Cardiac Surgery, Taubman Health Care Center, University of Michigan, Ann Arbor, Michigan 48109-0348, USA. sbolling@umich.edu
Insights
New surgical techniques for heart failure can improve survival and potentially delay or eliminate the need for heart transplantation in patients with advanced cardiomyopathy and secondary mitral regurgitation.
Area of Science:
- Cardiology
- Cardiac Surgery
Background:
- Heart failure is a major cause of hospitalization, characterized by cardiac remodeling and ventricular dilation.
- Secondary mitral regurgitation in end-stage cardiomyopathy historically presented high surgical risks, limiting treatment options.
- Heart transplantation is effective but limited to a small patient subset.
Purpose of the Study:
- To explore alternative surgical strategies for end-stage heart failure patients with secondary mitral regurgitation.
- To evaluate the impact of left ventricular remodeling procedures on survival and transplant avoidance.
Main Methods:
- Review of evolving surgical techniques including mitral valve annuloplasty and Batista procedure.
- Application of left ventricular shape-changing technologies in conjunction with medical heart failure management.
Main Results:
- Surgical interventions altering left ventricular shape improve survival rates.
- These techniques offer a viable alternative for patients who are not candidates for heart transplantation.
Conclusions:
- Innovative surgical approaches can significantly improve outcomes for heart failure patients.
- Altering left ventricular shape may allow patients to avoid or postpone heart transplantation.
Abstract:
Heart failure is one of the leading causes of hospitalization in the United States. Congestive heart failure is a chronic, progressive disease and its central element is remodeling of the cardiac chamber associated with ventricular dilation. Secondary mitral regurgitation is a complication of end-stage cardiomyopathy and is associated with poor prognosis. Historically, these patients were not considered operative candidates because of their high morbidity and mortality. Heart transplantation is now considered standard treatment for select patients with end-stage heart disease; however, it is applicable only to a small number of patients. In an effort to address this problem, newer and alternative surgical approaches are evolving, including mitral valve annuloplasty, the Batista procedure, and other left ventricular shape changing technologies. Using these operative techniques to alter the shape of the left ventricle, in combination with optimal medical management for heart failure, improves survival, and patients may avoid or postpone transplantation.